Navigation Links
SemBioSys updates progress on Apo AI(Milano)
Date:12/24/2009

TSX symbol: SBS

CALGARY, Dec. 24 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS) provided an update today on its progress on plant-produced Apo AI(Milano) in light of the Apo AI(Milano) license agreement between Pfizer Inc. and The Medicines Company, of Parsippany, New Jersey.

"The Medicines Company's acquisition of the exclusive rights to Pfizer's Apo AI(Milano) program is a strong endorsement of Apo AI(Milano) and its potential to rapidly reduce atherosclerotic plaque. The asset is now in the hands of pharmaceutical company that will actively develop the compound with access to the financial means to do so," said James Szarko, Chief Executive Officer of SemBioSys. "The Medicines Company, which specializes in acute cardiac care, recognizes the potential benefit and value of Apo AI(Milano) to address one of the most significant areas of unmet clinical need in the cardiovascular market today. While The Medicines Company did not address a manufacturing solution in their disclosure surrounding the transaction, it is clear that the success of this drug candidate will be highly dependent upon manufacturing technology that can provide Apo AI(Milano) at high purity and at a reasonable cost. Although SemBioSys' Apo AI(Milano) product is different and distinct from that in-licenced by The Medicines Company, our proprietary manufacturing technology is perfectly suited to making their in-licenced product as well as the natural forms of Apo AI."

In collaboration with leading cardiologists and cardiovascular researchers, SemBioSys has confirmed the activity of plant-derived Apo AI(Milano) in seven preclinical models. The Company has demonstrated the anti-atherosclerotic effects of Apo AI(Milano) based on cholesterol mobilization from the arterial wall, lipid content of atherosclerotic plaques, and the reduction of overall volume of atherosclerotic plaque after multiple injections. This year, the Company harvested more
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys securityholder vote to be held December 18, 2009 with a record date of November 16, 2009
2. SemBioSys announces third quarter 2009 financial and operational results
3. SemBioSys provides an update on Botaneco
4. Data for SemBioSys insulin to be presented at the American Diabetes Associations 69th Scientific Sessions
5. SemBioSys plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
6. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
7. SemBioSys provides update on insulin program
8. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
9. SemBioSys announces senior management changes
10. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
11. SemBioSys begins phase I/II trial of insulin produced in plant seeds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  An entire month is dedicated to ... – Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular disease ... muscle atrophy, weakness, and foot and hand deformities. CMT ... worldwide. CMT is a progressive disease, and over time ... mobility devices such as leg braces, wheelchairs and scooters ...
(Date:9/19/2014)... BioTech News Coverage: Progress made ... of studies and trials.  Companies in focus are: GenSpera ... LLY ), Gilead Sciences Inc. (NASDAQ: ... and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) GenSpera, ... for the treatment of cancer, announced that the United ...
(Date:9/19/2014)... 2014 , The first grants ... Paediatric Endocrinology (ESPE) Meeting  Investment supports innovative ... in the field of growth  , EMD ... Germany , today announced the first recipients of ... awards were announced during a Satellite Symposium organized by ...
(Date:9/18/2014)... 2014 About POCT ... a clinical laboratory. It helps in making fast ... and medication. POCT is gaining popularity due to ... such as diabetes, heart disease, and obesity. It ... standardized to minimize errors during the diagnosis of ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2
... High transduction efficiency and predictable copy number , ... , Katherine Felts John C. Bauer Peter ... pFB-Neo can be used with any,Moloney Murine Leukemia Virus ... be used to infect a wide range of cell ...
... expression of heterologous proteins , Carsten-Peter Carstens ... ,Stratagene , Codon bias is a significant obstacle ... hosts. In GC-rich genomes, such as mammals,rare arginine ... (CCC) most frequently,affect bacterial gene expression. For such ...
... mixture, TaqPlus Precision PCR system, developed for,highfidelity PCR ... Frances Bai * Daniel McMullan,* Barbara McGowan * Holly ... the addition of the TaqPlus Precision PCR system,* to ... PCR system,consists of a novel mixture of Taq2000 and ...
Cached Biology Technology:High-Titer ,Retroviral Vectors for Gene Delivery 2High-Titer ,Retroviral Vectors for Gene Delivery 3High-Titer ,Retroviral Vectors for Gene Delivery 4High-Titer ,Retroviral Vectors for Gene Delivery 5High-Titer ,Retroviral Vectors for Gene Delivery 6High-Titer ,Retroviral Vectors for Gene Delivery 7High-Titer ,Retroviral Vectors for Gene Delivery 8New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 2New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 3New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 4High-Fidelity PCR with a Novel Polymerase Mixture 2High-Fidelity PCR with a Novel Polymerase Mixture 3High-Fidelity PCR with a Novel Polymerase Mixture 4High-Fidelity PCR with a Novel Polymerase Mixture 5High-Fidelity PCR with a Novel Polymerase Mixture 6High-Fidelity PCR with a Novel Polymerase Mixture 7High-Fidelity PCR with a Novel Polymerase Mixture 8High-Fidelity PCR with a Novel Polymerase Mixture 9High-Fidelity PCR with a Novel Polymerase Mixture 10High-Fidelity PCR with a Novel Polymerase Mixture 11
(Date:9/18/2014)... acquire and creatively manipulate spoken language is unique to ... 6 million years of human evolution to make this ... candidate gene we now have," says Wolfgang Enard, Professor ... efforts to understand the molecular biological basis of language ... results of his latest study, undertaken in collaboration with ...
(Date:9/18/2014)... turned its newborn screening program into a model other states ... the first-ever Newborn Screening Quality Award from the March of ... M.P.H., Arizona,s Department of Health Services director, with the award ... policy of full transparency for the length of time it ... lab for analysis, and set a target of having 95 ...
(Date:9/18/2014)... Eight researchers from several disciplines will be celebrated tonight ... their roles in improving the health of premature infants ... supercomputing revolutions. The researchers, whose work was supported by ... and the former Atomic Energy Commission, will be honored ... Washington, DC. A bipartisan group of Members of Congress ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 33rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2
... (BRONX, NY) Researchers from the Albert Einstein ... developed an onsite method to quickly diagnose tuberculosis (TB) ... undetected with treatable TB strains. This study will ... online journal from the Public Library of Science. ...
... 19, 2009Recognition of the benefits of cooling strategies to ... has led to a wealth of cutting edge research, ... hypothermia issue of Journal of Neurotrauma , a ... www.liebertpub.com ). The issue will be available free online ...
... is 2065. Nearly two-thirds of Earth,s ozone is gone -- ... hole over Antarctica, first discovered in the 1980s, is a ... ultraviolet (UV) radiation falling on mid-latitude cities like Washington, D.C., ... DNA-mutating UV radiation is up 650 percent, with likely harmful ...
Cached Biology News:Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time 2Therapeutic hypothermia is promising strategy to minimize tissue damage 2New simulation shows consequences of a world without Earth's natural sunscreen 2New simulation shows consequences of a world without Earth's natural sunscreen 3New simulation shows consequences of a world without Earth's natural sunscreen 4
Mouse GM CSF Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Request Info...
... Storage Racks for Standard 3" Boxes. ... all makes and models of upright ... high quality stainless steel and can ... steel or plastic boxes. Custom ...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: